Literature DB >> 11955431

Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor.

Brian O Smith1, Rosie L Mallin, Malgorzata Krych-Goldberg, Xuefeng Wang, Richard E Hauhart, Krystyna Bromek, Dusan Uhrin, John P Atkinson, Paul N Barlow.   

Abstract

Complement receptor type 1 (CR1 or CD35) is a multiple modular protein that mediates the immune adherence phenomenon, a fundamental event for destroying microbes and initiating an immunological response. It fulfills this role through binding C3b/C4b-opsonized foreign antigens. The structure of the principal C3b/C4b binding site (residues 901-1095) of CR1 is reported, revealing three complement control protein modules (modules 15-17) in an extended head-to-tail arrangement with flexibility at the 16-17 junction. Structure-guided mutagenesis identified a positively charged surface region on module 15 that is critical for C4b binding. This patch, together with basic side chains of module 16 exposed on the same face of CR1, is required for C3b binding. These studies reveal the initial structural details of one of the first receptor-ligand interactions to be identified in immunobiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955431     DOI: 10.1016/s0092-8674(02)00672-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  31 in total

1.  Letter to the Editor: Resonance assignments of the central complement control protein module pair of human decay accelerating factor.

Authors:  Stanislava Uhrínová; Feng Lin; Du Usan Uhrín; M Edward Medof; Paul N Barlow
Journal:  J Biomol NMR       Date:  2002-06       Impact factor: 2.835

2.  Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.

Authors:  Li Zhang; Dimitrios Morikis
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

3.  The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

Review 4.  Do follicular dendritic cells regulate lupus-specific B cells?

Authors:  Balthasar A Heesters; Abhishek Das; Priyadarshini Chatterjee; Michael C Carroll
Journal:  Mol Immunol       Date:  2014-03-14       Impact factor: 4.407

5.  Solution structure of a functionally active fragment of decay-accelerating factor.

Authors:  Stanislava Uhrinova; Feng Lin; Graeme Ball; Krystyna Bromek; Dusan Uhrin; M Edward Medof; Paul N Barlow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

6.  Identification of a complement receptor 1 peptide for inhibition of immune hemolysis.

Authors:  Jin Yu; Susanne Heck; Asim Debnath; Karina Yazdanbakhsh
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

7.  Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Authors:  Hyon Ju Park; Mara Guariento; Mateusz Maciejewski; Richard Hauhart; Wai-Hong Tham; Alan F Cowman; Christoph Q Schmidt; Haydyn D T Mertens; M Kathryn Liszewski; Dennis E Hourcade; Paul N Barlow; John P Atkinson
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

8.  The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.

Authors:  Andrea E Prota; David R Sage; Thilo Stehle; Joyce D Fingeroth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

9.  Severity of malaria in relation to a complement receptor 1 polymorphism: a case-control study.

Authors:  Rebecca Tettey; Patrick Ayeh-Kumi; Prudence Tettey; George O Adjei; Richard H Asmah; Daniel Dodoo
Journal:  Pathog Glob Health       Date:  2015-04-27       Impact factor: 2.894

10.  Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.

Authors:  Vannakambadi K Ganesh; Scott A Smith; Girish J Kotwal; Krishna H M Murthy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.